» Articles » PMID: 33664232

Impairment in Inflammasome Signaling by the Chronic Pseudomonas Aeruginosa Isolates from Cystic Fibrosis Patients Results in an Increase in Inflammatory Response

Overview
Journal Cell Death Dis
Date 2021 Mar 5
PMID 33664232
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa is a common respiratory pathogen in cystic fibrosis (CF) patients which undergoes adaptations during chronic infection towards reduced virulence, which can facilitate bacterial evasion of killing by host cells. However, inflammatory cytokines are often found to be elevated in CF patients, and it is unknown how chronic P. aeruginosa infection can be paradoxically associated with both diminished virulence in vitro and increased inflammation and disease progression. Thus, we investigated the relationship between the stimulation of inflammatory cell death pathways by CF P. aeruginosa respiratory isolates and the expression of key inflammatory cytokines. We show that early respiratory isolates of P. aeruginosa from CF patients potently induce inflammasome signaling, cell death, and expression of IL-1β by macrophages, yet little expression of other inflammatory cytokines (TNF, IL-6 and IL-8). In contrast, chronic P. aeruginosa isolates induce relatively poor macrophage inflammasome signaling, cell death, and IL-1β expression but paradoxically excessive production of TNF, IL-6 and IL-8 compared to early P. aeruginosa isolates. Using various mutants of P. aeruginosa, we show that the premature cell death of macrophages caused by virulent bacteria compromises their ability to express cytokines. Contrary to the belief that chronic P. aeruginosa isolates are less pathogenic, we reveal that infections with chronic P. aeruginosa isolates result in increased cytokine induction due to their failure to induce immune cell death, which results in a relatively intense inflammation compared with early isolates.

Citing Articles

A VgrG2b fragment cleaved by caspase-11/4 promotes infection through suppressing the NLRP3 inflammasome.

Qian Y, Liu Q, Cheng X, Wang C, Kong C, Li M Elife. 2025; 13.

PMID: 39998486 PMC: 11856931. DOI: 10.7554/eLife.99939.


Establishment and characterization of persistent infections in air-liquid interface cultures of human airway epithelial cells.

Bouheraoua S, Cleeves S, Preusse M, Musken M, Braubach P, Fuchs M Infect Immun. 2025; 93(3):e0060324.

PMID: 39964154 PMC: 11895474. DOI: 10.1128/iai.00603-24.


Uncovering a new family of conserved virulence factors that promote the production of host-damaging outer membrane vesicles in gram-negative bacteria.

Goman A, Ize B, Jeannot K, Pin C, Payros D, Goursat C J Extracell Vesicles. 2025; 14(1):e270032.

PMID: 39840902 PMC: 11752146. DOI: 10.1002/jev2.70032.


Regulation of Zfp36 by ISGF3 and MK2 restricts the expression of inflammatory cytokines during necroptosis stimulation.

Yadav S, El Hamra R, Alturki N, Ariana A, Bhan A, Hurley K Cell Death Dis. 2024; 15(8):574.

PMID: 39117638 PMC: 11310327. DOI: 10.1038/s41419-024-06964-4.


in chronic lung disease: untangling the dysregulated host immune response.

Nickerson R, Thornton C, Johnston B, Lee A, Cheng Z Front Immunol. 2024; 15:1405376.

PMID: 39015565 PMC: 11250099. DOI: 10.3389/fimmu.2024.1405376.


References
1.
Regelmann W, Elliott G, Warwick W, Clawson C . Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis. 1990; 141(4 Pt 1):914-21. DOI: 10.1164/ajrccm/141.4_Pt_1.914. View

2.
Beaudoin T, LaFayette S, Roussel L, Berube J, Desrosiers M, Nguyen D . The level of p38α mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa. J Infect Dis. 2013; 207(10):1544-55. DOI: 10.1093/infdis/jit059. View

3.
Wang H, Cebotaru L, Lee H, Yang Q, Pollard B, Pollard H . CFTR Controls the Activity of NF-κB by Enhancing the Degradation of TRADD. Cell Physiol Biochem. 2016; 40(5):1063-1078. PMC: 7067292. DOI: 10.1159/000453162. View

4.
Ordonez C, Henig N, Mayer-Hamblett N, Accurso F, Burns J, Chmiel J . Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med. 2003; 168(12):1471-5. DOI: 10.1164/rccm.200306-731OC. View

5.
Kalliolias G, Ivashkiv L . TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2015; 12(1):49-62. PMC: 4809675. DOI: 10.1038/nrrheum.2015.169. View